Retrospective study of rapamycin or rapalog 0·1% cream for facial angiofibromas in tuberous sclerosis complex: evaluation of treatment effectiveness and cost. (1st July 2018) - Norrenberg, S.; Masconi, M.; Karamanou, M.; Meylan, P.; Golaz, R.; Christen‐Zaech, S.